Head Assay Development and Automation
Hubrecht Organoid Technology (HUB), Utrecht, Netherlands
René received his PhD in Biology from the Leiden University Medical Center on a molecular study of DNA damage repair. He subsequently moved to University Medical Center Utrecht to do his Post Doc studying Ras/Rap cancer signaling. During this period, he started working with adult stem cell derived Organoid Technology and developed the first drug screens together with the group of Hans Clevers. He continued this work in the newly formed ‘Hubrecht Organoid Technology’ (HUB) where he became responsible for development of new assays and high throughput screening.
Disclosure information not submitted.
Wednesday, February 9, 2022
10:00 AM – 10:30 AM